Doctor of Philosophy – Molecular Genetics; University of Wales College of Medicine, Cardiff
Master of Philosophy – Clinical Immunology; University of Wales College of Medicine, Cardiff
Bachelor of Science (Hons) – Biochemistry; University of Wales College of Swansea
Based at the Genomics Policy Unit (GPU) in the Faculty of Health, Sport and Science at the University of Glamorgan, Rhian has held the position of Telling Stories Understanding Real Life Genetics Project Officer since 2008, where she has responsibility for managing the project on a daily basis.
Telling Stories Understanding Real Life Genetics (www.tellingstories.nhs.uk) is an award-winning, genetics education resource which uses real stories from individuals and families with, or at risk of, a genetic condition or from those who care for them. It was developed to promote understanding of the impact genetics can have on everyday life and its relevance to healthcare practice.
Rhian’s role is varied and ranges from interviewing storytellers to collect their stories, to developing educational content to accompany the stories, monitoring website statistics, and promoting the resource through publications and at conferences, workshops, meetings and via social-media.
In June 2011, Rhian was seconded to the post of Wales Development Officer for Genetic Alliance UK – the national charity of patient organisations supporting all those affected by genetic disorders – and more recently has also undertaken a secondment to the Wales Gene Park as acting Public Engagement Officer, combining this role with her work on the Telling Stories project.
Rhian’s background is in scientific research and she has worked in academic, industrial and clinical research settings. She graduated from Swansea University in Biochemistry before moving to the Department of Medical Biochemistry, University of Wales College of Medicine in Cardiff where she completed her Master of Philosophy degree on the role of complement in male infertility.
In 2002 Rhian obtained her PhD from the University of Wales College of Medicine, Cardiff where she undertook research into the molecular genetics underlying Variegate Porphyria, an inherited disorder of haem biosynthesis. She then moved to an industrial setting, working as a research scientist, and later R & D manager, for GenProbe (formerly Molecular Light Technology Ltd) on nucleic acid-based molecular diagnostics. She has also undertaken research in NHS laboratories on Rett syndrome, muscular dystrophy and neurofibromatosis.
A member of the Genomics Policy Unit, she is interested in genetics education, policy work and public engagement and as a member of the Faculty Research Office, she also undertakes some teaching and research supervision activities.
Clancy T and Morgan R (2013) Tailoring genetic/genomic services and information to the individual. Nursing Standard, 28, 10, 37-43 (http://dx.doi.org/10.7748/ns2013.11.28.10.37.e7844)
Kirk M, Morgan R, Tonkin E, McDonald K, Skirton H (2012) An objective approach to evaluating an internet-delivered genetics education resource developed for nurses: using Google Analytics™ to monitor global visitor engagement. Journal of Research in Nursing 17 (6):557-579 doi: 10.1177/1744987112458669
Kirk, M, Tonkin, E, Skirton, H, McDonald K, Cope, B, Morgan, R
Storytellers as partners in developing a genetics education resource for health professionals. Nurse Education Today 2011, doi:10.1016/j.nedt.2011.11.019
Morgan R, Tonkin E, Kirk M
A chance to be heard: what motivates people to tell their healthcare stories? Interconnection Quarterly Journal, 2009, 2(5) Online journal available at (www.icwhatnew.com)
Morris CA, Blackwood AD, Kirs M, Buttigieg ND, Morgan RR, Hogan JJ, Weeks I, Noble RT Comparison of Transcription-Mediated Amplification and growth-based methods for the quantification of Enterococcus in estuarine waters. Appl. Environ. Microbiol. 2008, 74 (10): 3319-3320
Morgan R, Morris C, Livezey K, Hogan J, Buttigieg N, Pollner R, Kacian D, Weeks I.
Rapid Tests for Detection and Quantitation of Enterococcus Contamination in Recreational Waters. J. Environ. Monit., 2007, 9: 424 – 426.
Morgan R, Azzopardi D, Roberts K, Morris C, Woodhead S. Development of Chemiluminescent assays for measuring cytochrome p450 gene expression. Toxicology 2004, 202: 92.
Thomas-Jones E, Morris C, Morgan R, Walkley N, Rutter A, Woodhead S. Measuring gene activity in response to environmental stress. Marine Environ. Res. 2004, 58: 694.
Laccone F, Junemann I, Whatley S, Morgan R, Butler R, Huppke P,and Ravine D. Large Deletions of the MECP2 Gene Detected by Gene Dosage Analysis in Patients With Rett Syndrome. Human Mutation 2004, 23:234-244.
Morgan RR, Errington R, Elder GH.
Identification of sequences required for the import of human Protoporphyrinogen Oxidase to mitochondria. Biochem J. 2004, 377(2):281-7
Morgan RR, da Silva V, Puy H, Deybach JC, Elder GH. Functional studies of mutations in the human Protoporphyrinogen Oxidase gene in variegate porphyria. Cell Mol Biol (Noisy-le-grand). 2002 48(1):79-82
Chow KM, Hui CF, Lam CW, Morgan RR, Whatley SD, Kay R, Wong KS.
Clinical and genetic features of variegate Porphyria in a Chinese patient.
Chin Med J (Engl). 2001, 114(4):424-7
Brady JJ, Jackson HA, Roberts AG, Morgan RR, Whatley SD, Rowlands GL, Darby C, Shudell E, Watson R, Paiker J, Worwood MW, Elder GH. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda. J Invest Dermatol. 2000, 115(5): 868-74
Whatley SD, Puy H, Morgan RR, Robreau AM, Roberts AG, Nordmann Y, Elder GH, Deybach JC. Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet. 199, 65(4): 984-94
Roberts AG, Puy H, Dailey TA, Morgan RR, Whatley SD, Dailey HA, Martasek P, Nordmann Y, Deybach JC, Elder GH. Molecular characterization of homozygous variegate porphyria. Hum Mol Genet. 1998, 7(12): 1921-5
Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the Haemochromatosis Cys282Tyr mutation in sporadic Porphyria Cutanea Tarda. Lancet. 1997, 1, 349(9048): 321-3
If you are a journalist on deadline and you need to speak with a member of university staff with particular expertise, please contact the Press Office.